Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
The article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2357 |
_version_ | 1797841656354963456 |
---|---|
author | A. M. Esayan A. N. Nimgirova |
author_facet | A. M. Esayan A. N. Nimgirova |
author_sort | A. M. Esayan |
collection | DOAJ |
description | The article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various stages including terminal renal failure, dialysis therapy, and kidney transplantation. |
first_indexed | 2024-04-09T16:34:51Z |
format | Article |
id | doaj.art-cb1364585b634788990b1f867738e4f7 |
institution | Directory Open Access Journal |
issn | 2079-701X 2658-5790 |
language | Russian |
last_indexed | 2024-04-09T16:34:51Z |
publishDate | 2018-04-01 |
publisher | Remedium Group LLC |
record_format | Article |
series | Медицинский совет |
spelling | doaj.art-cb1364585b634788990b1f867738e4f72023-04-23T06:56:57ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-04-0105586310.21518/2079-701X-2018-5-58-632333Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotectionA. M. Esayan0A. N. Nimgirova1Pavlov First Saint Petersburg State Medical UniversityPavlov First Saint Petersburg State Medical UniversityThe article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various stages including terminal renal failure, dialysis therapy, and kidney transplantation.https://www.med-sovet.pro/jour/article/view/2357aldosteronemineralocorticoid receptor antagonistsheart failurechronic kidney diseasedialysiskidney transplantation |
spellingShingle | A. M. Esayan A. N. Nimgirova Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection Медицинский совет aldosterone mineralocorticoid receptor antagonists heart failure chronic kidney disease dialysis kidney transplantation |
title | Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
title_full | Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
title_fullStr | Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
title_full_unstemmed | Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
title_short | Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
title_sort | mineralocorticoid receptor antagonists new extended roles in cardio and nephroprotection |
topic | aldosterone mineralocorticoid receptor antagonists heart failure chronic kidney disease dialysis kidney transplantation |
url | https://www.med-sovet.pro/jour/article/view/2357 |
work_keys_str_mv | AT amesayan mineralocorticoidreceptorantagonistsnewextendedrolesincardioandnephroprotection AT annimgirova mineralocorticoidreceptorantagonistsnewextendedrolesincardioandnephroprotection |